Salix Coronary Plaque vs uOmnispace.MR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Salix Coronary Plaque

by Artrya Limited

uOmnispace.MR

by Shanghai United Imaging Healthcare Co., Ltd.

AI Verdict

Tool A is specifically designed for the assessment of coronary artery plaque and stenosis using CCTA scans, providing a focused solution for coronary artery disease diagnosis. In contrast, Tool B offers a broader AI-powered platform for comprehensive MR image analysis across multiple specialties, including general cardiac function analysis. The choice between them depends on whether the primary need is CCTA-based coronary plaque analysis or a versatile MR imaging analysis tool for diverse clinical applications.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your primary need is rapid, AI-driven assessment of coronary artery plaque and stenosis directly from CCTA scans at the point of care. This tool is ideal for quickly identifying and quantifying high-risk plaque features and calcifications to aid in the immediate diagnosis and management of coronary artery disease.

View Salix Coronary Plaque →

Choose uOmnispace.MR if…

Choose uOmnispace.MR if you require a comprehensive AI-powered platform for advanced magnetic resonance image analysis across diverse clinical applications, including brain, breast, and cardiac imaging. This tool is best suited for detailed diagnostic workups that benefit from AI-driven segmentation, advanced post-processing, and multi-user access for a wide range of MR studies.

View uOmnispace.MR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Salix Coronary Plaque	uOmnispace.MR
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud	Software-only medical device; can run standalone or integrated with other cleared applications on standard off-the-shelf PCs; supports remote multi-user access on a network. The broader uOmnispace platform is available as SaaS, on-premise, or hybrid.
FDA Status	Yes AI-estimated	1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Salix Coronary Plaque	uOmnispace.MR
Product Name	Salix Coronary Plaque	uOmnispace.MR
Company	Artrya Limited	Shanghai United Imaging Healthcare Co., Ltd.
Primary Imaging Modality	CCTA scans	Magnetic Resonance (MR) image analysis
Key Clinical Focus/Categories	Cardiology AI	Cardiology AI, Neurology AI, Oncology AI
Specific Feature: Plaque Analysis	Detection and quantification of coronary plaque (atherosclerosis), identification of high-risk plaque features	Not specified
Specific Feature: Stenosis Assessment	Stenosis assessment	Not specified
Specific Feature: Multi-Specialty Support	Not specified	Yes (brain, breast, cardiac imaging)

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and uOmnispace.MR.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary imaging modalities and clinical applications supported by each tool?

Salix Coronary Plaque is an AI-driven software that assesses coronary artery plaque and stenosis from CCTA scans, primarily aiding in the diagnosis of coronary artery disease. In contrast, uOmnispace.MR is an AI-powered software for comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications including brain, breast, and cardiac imaging.

How do the cardiac analysis capabilities differ between Salix Coronary Plaque and uOmnispace.MR?

Salix Coronary Plaque focuses on the detection and quantification of coronary plaque, identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification), stenosis assessment, and calcium scoring from CCTA scans. uOmnispace.MR offers AI-driven cardiac ventricular segmentation and cardiac function analysis from MR images, along with dynamic studies and perfusion analysis.

Is there specific information regarding reimbursement for these tools?

Salix Coronary Plaque qualifies for a Category I CPT code for automated plaque analysis of CCTA scans, with a US CPT reimbursement rate of US$950 per assessment. The provided information for uOmnispace.MR does not explicitly state specific reimbursement rates or CPT codes.

Does either tool provide explicit support for identifying high-risk plaque features?

Yes, Salix Coronary Plaque explicitly identifies high-risk plaque features such as low-attenuation plaque, spotty calcification, positive remodeling, and the napkin-ring sign. This feature is not explicitly mentioned in the description for uOmnispace.MR.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform